Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mewburn Ellis is a leading European intellectual property firm that provides specialist legal services to the life sciences, pharmaceutical, and biotechnology industries. Founded in 1867, the firm excels in patent and trademark prosecution, IP portfolio management, and strategic advisory for complex scientific innovations. Their life sciences team is one of the largest in Europe, handling cases involving biologics, gene editing, and small molecule therapeutics. Mewburn Ellis supports a diverse clientele ranging from venture-backed startups to multinational pharmaceutical corporations and prestigious academic institutions. The firm is recognized for its deep technical expertise, with many attorneys holding PhDs in specialized fields such as molecular biology and biochemistry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mewburn Ellis.